Skip to main content
. 2021 Jun 8;37(5):434–442. doi: 10.1159/000516424

Table 3.

TG13 and TG18 diagnostic criteria

n = 262 Did not meet the criteria
(n = 39)
Suspected diagnosis
(n = 28)
Definite diagnosis
(n = 195)
p value
Age, years 75.4 (59.7–82.5) 81.71 (66.3–83.1) 75.5 (64.8–82.6) 0.627
Male gender 16 (41.0) 13 (46.4) 100 (51.3) 0.48
Diabetes mellitus 12 (30.8) 17 (60.7) 71 (36.4) 0.027
Ischemic heart disease 8 (20.5) 6 (21.4) 39 (20.0) 0.984
COPD/asthma 2 (5.1) 1 (3.6) 9 (4.6) 0.955
Chronic renal impairment 3 (7.7) 3 (10.7) 32 (16.4) 0.308
History of biliary disease 16 (41.0) 17 (60.7) 103 (52.8) 0.248
Abdominal pain 29 (74.4) 14 (50.0) 135 (69.2) 0.081
Pyrexia 13 (33.3) 20 (71.4) 123 (63.1) 0.001
Vomiting 20 (51.3) 15 (53.6) 88 (45.1) 0.593
Jaundice 7 (17.9) 4 (14.3) 56 (28.7) 0.13
Abdominal tenderness 25 (64.1) 8 (28.6) 103 (52.8) 0.014
Arrythmia 0 (0.0) 0 (0.0) 3 (1.5) 0.594
Ionotrope use 1 (2.6) 3 (10.7) 15 (7.7) 0.401
Total positive blood cultures, n 12 11 72 0.397
  Monomicrobial 12 (100.0) 10 (90.9) 57 (79.2)
  Polymicrobial 0 (0.0) 1 (9.1) 15 (20.8)
Cholelithiasis 28 (71.8) 13 (46.4) 145 (74.4) 0.010
Malignancy 5 (12.8) 1 (3.6) 39 (20.0) 0.072
Ultrasound 18 (46.2) 5 (17.9) 48 (24.6) 0.011
CT scan 18 (46.2) 11 (39.3) 75 (38.5) 0.668
MRCP scan 15 (38.5) 11 (39.3) 90 (46.2) 0.578
ERCP 17 (43.6) 9 (32.1) 120 (61.5) 0.003

Values are presented as medians (IQR), numbers (%), or numbers. COPD, chronic obstructive pulmonary disease; MRCP, magnetic resonance cholangiopancreatography.